Robert Steckmeyer
Family · Monroe, MINPI 1104194638
Payments from drug & device makers
Across 180 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$504
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$329
- Teva Pharmaceuticals USA, Inc.$249
- Exact Sciences$126
- Lilly USA, LLC$104
- plus $827 from 21 others
What the payments were for
- Food & beverage$3,440100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 64 | $1,302 |
| Novo Nordisk | 26 | $504 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 19 | $329 |
| Teva Pharmaceuticals USA, Inc. | 13 | $249 |
| Exact Sciences | 6 | $126 |
| Lilly USA, LLC | 8 | $104 |
| Axsome Therapeutics, Inc. | 5 | $95 |
| Otsuka America Pharmaceutical, Inc. | 5 | $93 |
| Alkermes, Inc. | 3 | $88 |
| GSK | 4 | $76 |
| Pfizer | 4 | $72 |
| Lundbeck LLC | 3 | $61 |
| Sanofi Pasteur Inc. | 3 | $61 |
| Actelion Pharmaceuticals US, Inc. | 3 | $51 |
| Indivior Inc. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Corium, LLC | 1 | $19 |
| Viatris Specialty LLC | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| AstraZeneca | 1 | $16 |
| Amgen | 1 | $15 |
| Novartis | 1 | $15 |
| Ascensia Diabetes Care US Inc. | 1 | $15 |
| Insulet Corporation | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Neurocrine Biosciences, Inc. | 1 | $13 |
How this compares
$3,440 in reported general payments places this provider in the 90th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 65 | $62,170 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 69 | $49,335 |
| JardianceEmpagliflozin | 42 | $37,266 |
| MounjaroTirzepatide | 31 | $31,092 |
| JanuviaSitagliptin Phosphate | 28 | $27,014 |
| FarxigaDapagliflozin Propanediol | 25 | $24,481 |
| VraylarCariprazine Hcl | 15 | $23,033 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 37 | $19,751 |
| TrulicityDulaglutide | 16 | $14,626 |
| SymbicortBudesonide/Formoterol Fumarate | 20 | $10,075 |
| Advair HfaFluticasone Propion/Salmeterol | 23 | $9,500 |
| Breo ElliptaFluticasone/Vilanterol | 22 | $9,009 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 137 | $4,893 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $4,682 |
| Atorvastatin Calcium | 377 | $3,549 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $504 | $62,17065 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $76 | $58,34491 claims |
| Lilly USA, LLCMounjaro, Trulicity | $104 | $45,71847 claims |
| AstraZenecaFarxiga, Symbicort | $16 | $34,55545 claims |
| AbbVieVraylar | $1,302 | $23,03315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,657 family providers in Michigan.
Other family in Monroe
- Lane JudgeMonroe$39K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.